PRKN and nasopharyngeal carcinoma: It should be noted that in NPC of the majority of patients, the increase of HOX gene expression was observed, while in TDNs, the HOX activation was the characteristic presumably of PD2 and PD3 cells from patients with mutations in the PARK2 gene.